These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 890504)

  • 1. delta9-tetrahydrocannabinol and the hippocampus: effects on CA1 field potentials in rats.
    Vardaris RM; Weisz DJ
    Brain Res Bull; 1977; 2(3):181-7. PubMed ID: 890504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in hippocampal CA1 population spikes following administration of delta-9-THC.
    Weisz DJ; Gunnell DL; Teyler TJ; Vardaris RM
    Brain Res Bull; 1982 Feb; 8(2):155-62. PubMed ID: 6279250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. delta 9-Tetrahydrocannabinol and cannabidiol: dose-dependent effects on evoked potentials in the hippocampal slice.
    Kujtan PW; Carlen PL; Kapur BM
    Can J Physiol Pharmacol; 1983 Apr; 61(4):420-6. PubMed ID: 6305469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actions of THC on the intact hippocampus: a comparison of dentate and CA1 responses.
    Wilkison DM; Pontzer NJ
    Brain Res Bull; 1987 Jul; 19(1):63-7. PubMed ID: 2820552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
    Shen M; Thayer SA
    Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA(B) receptors inhibit backpropagating dendritic spikes in hippocampal CA1 pyramidal cells in vivo.
    Leung LS; Peloquin P
    Hippocampus; 2006; 16(4):388-407. PubMed ID: 16411229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro.
    Nowicky AV; Teyler TJ; Vardaris RM
    Brain Res Bull; 1987 Dec; 19(6):663-72. PubMed ID: 2830949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low concentrations of 4-aminopyridine on CA1 pyramidal cells of the hippocampus.
    Perreault P; Avoli M
    J Neurophysiol; 1989 May; 61(5):953-70. PubMed ID: 2566657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delta9-tetrahydrocannabinol and pentobarbital on a cortical response evoked during conditioning.
    Boyd ES; Boyd EH; Brown LE
    Psychopharmacology (Berl); 1976 May; 47(1):119-22. PubMed ID: 822438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsynaptic potentials mediated by excitatory and inhibitory amino acids in interneurons of stratum pyramidale of the CA1 region of rat hippocampal slices in vitro.
    Lacaille JC
    J Neurophysiol; 1991 Nov; 66(5):1441-54. PubMed ID: 1684988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolonged elevation of potassium on hippocampus of anesthetized rats.
    Herreras O; Somjen GG
    Brain Res; 1993 Jul; 617(2):194-204. PubMed ID: 8402147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of baclofen and bicuculline on inhibition in the fascia dentata and hippocampus regio superior.
    Steffensen SC; Henriksen SJ
    Brain Res; 1991 Jan; 538(1):46-53. PubMed ID: 1850318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monosynaptic GABA-mediated inhibitory postsynaptic potentials in CA1 pyramidal cells of hyperexcitable hippocampal slices from kainic acid-treated rats.
    Williams S; Vachon P; Lacaille JC
    Neuroscience; 1993 Feb; 52(3):541-54. PubMed ID: 8095707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired-pulse depression of excitatory postsynaptic current sinks in hippocampal CA1 in vivo.
    Leung LS; Peloquin P; Canning KJ
    Hippocampus; 2008; 18(10):1008-20. PubMed ID: 18548580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trifluoperazine on synaptically evoked potentials and membrane properties of CA1 pyramidal neurons of rat hippocampus in situ and in vitro.
    Agopyan N; Krnjević K
    Synapse; 1993 Jan; 13(1):10-9. PubMed ID: 7678946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of GABA-mediated inhibitory postsynaptic potentials in hippocampal CA1 pyramidal neurons following oral flurazepam administration.
    Zeng X; Xie XH; Tietz EI
    Neuroscience; 1995 May; 66(1):87-99. PubMed ID: 7637878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus.
    Swann JW; Brady RJ; Martin DL
    Neuroscience; 1989; 28(3):551-61. PubMed ID: 2710330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory nature of tiagabine-augmented GABAA receptor-mediated depolarizing responses in hippocampal pyramidal cells.
    Jackson MF; Esplin B; Capek R
    J Neurophysiol; 1999 Mar; 81(3):1192-8. PubMed ID: 10085346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of GABA A receptor-mediated IPSCs to cannabinoids in hippocampal slices from adolescent and adult rats.
    Kang-Park MH; Wilson WA; Kuhn CM; Moore SD; Swartzwelder HS
    J Neurophysiol; 2007 Sep; 98(3):1223-30. PubMed ID: 17634345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of ethanol and chlordiazepoxide on electrophysiological activity in the fascia dentata and hippocampus regio superior.
    Steffensen SC; Henriksen SJ
    Hippocampus; 1992 Apr; 2(2):201-11. PubMed ID: 1308183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.